Paradise Vitamin D3 + K2 supplement combines two essential fat-soluble nutrients to support strong bones, a healthy heart, and immune balance. Vitamin D3 (cholecalciferol) aids calcium absorption, while Vitamin K2 (menaquinone-7) directs calcium to bones and away from arteries, promoting proper calcium utilization. Sourced from natural, clean ingredients, this formula is free from artificial additives, allergens, and fillers. It supports skeletal strength, cardiovascular function, and immune health in a highly bioavailable and easy-to-digest form. Ideal for individuals with low sun exposure or dietary deficiencies, Paradise D3 + K2 is a daily essential for maintaining long-term wellness and vitality.
Vitamin D3 (Cholecalciferol) – 125 mcg (5,000 IU)
Vitamin K2 (as MenaQ7® MK-7, Menaquinone-7) – 100 mcg
Other ingredients: Extra virgin olive oil (for enhanced absorption), vegetarian softgel (non-GMO, plant-based gelatin)
Free from: Gluten, soy, dairy, wheat, corn, artificial colors, preservatives, and common allergens
Paradise uses clinically studied MenaQ7® for superior K2 absorption and stability.
Bone Health: Vitamin D3 enhances calcium absorption; K2 ensures calcium is deposited into bones, not arteries.
Cardiovascular Support: K2 helps reduce arterial calcification and supports flexible, healthy blood vessels.
Immune Function: Vitamin D3 plays a critical role in activating immune defenses and reducing inflammation.
Joint and Muscle Support: Improves muscle function and reduces stiffness and joint discomfort.
Mood and Energy: Supports emotional well-being and combats fatigue associated with Vitamin D deficiency.
Calcium Balance: Helps regulate calcium levels, ensuring it benefits bones without harming arteries.
Synergistic Formula: Combines D3 and K2 for better absorption and utilization than D3 alone.
Dosage: Take 1 softgel daily with food or as directed by a healthcare provider.
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.